MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.

Schuman-Olivier, Zev.

Borodovsky, Jacob T.

Steinkamp, Jackson.

Munir, Qays.

Butler, Kyle.

Greene, Mary Ann.

Goldblatt, Jonah.

Xie, Hai Yi.

Marsch, Lisa A.


  • Background: While buprenorphine/naloxone (B/N) is approved for opioid use disorder treatment, effective delivery of B/N comes with significant challenges. Most notably, many patients do not take medication daily as prescribed; this non-adherence worsens treatment outcomes, increases healthcare costs, and leads to persistent worries of diversion among providers and policymakers. The present study ... read more
This object is in collection Permanent URL
To Cite:
TARC Citation Guide    EndNote
Detailed Rights